Valion Bio (VBIO) Amortizatization of Intangibles (2021)
Valion Bio (VBIO) posted quarterly Amortizatization of Intangibles of $134000.0 for Q4 2021, down 88.29% quarter-over-quarter from $1.1 million in Q3 2021.
Valion Bio (VBIO) Amortizatization of Intangibles (2021) Analysis & Trends
Valion Bio's Amortizatization of Intangibles history runs 1 years deep, the most recent figure standing at $134000.0 for Q4 2021.
- In Q4 2021, Amortizatization of Intangibles changed N/A year-over-year to $134000.0; the TTM figure through Dec 2021 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $97000.0, changed N/A from the prior year.
- Amortizatization of Intangibles for Q4 2021 stood at $134000.0, down from $1.1 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.1 million in Q3 2021, with the low at $134000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 134,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 176,000.00 |
| Jun 30, 2021 | 176,000.00 |
| Mar 31, 2021 | 261,000.00 |
| Mar 31, 2021 | 261,000.00 |